Member Centre       Download


Follow us

Free newsletter sign up

Sign up to our free newsletter and get the latest 

news sent direct to your inbox

Etta Biotech Co., Ltd.  Copyright © 2014-2018 All Rights Reserved.   苏ICP备13031692号-4

  • F1


  • H1


  • HiDEN


Recent Updates

View all

Etta Biotech 「invites」 you to meet Beijing · 2019.1.21-22
The 9th Asia Pharma R&D Leaders, as one of the top strategic summits with the theme of R&D in the pharmaceutical industry in Asia, is about to open at Four Points By Sheraton Beijing, Haidian. By keynote speech, roundtable discussion, company showcase, exhibition booth and 1-2-1 meeting system, this two-day event will share insightful ideas from Asian pharmaceutical leaders, as well as provide fat chances for you to find potential projects and partners. Etta Biotech Co., Ltd. will bring Etta Cell Electroporator X-Porator H1 PLUS and Etta Flow Electroporator X-Porator F1 to the ceremony !
Within two months, we have received three orders of Etta flow electroporator X-Porator F1!
Etta has completed A-round of financing, dedicated to creating world-class electrotransfection products to help cancer treatment
Come, follow CCTV finance channel "the first time", "CCTV finance and economics" to know Etta Biotech

User Testimony

Dr. Li

PhD student, Shandong University

"22RV1 cell gene editing efficiency meets customer

requirements and homologous repair efficiency is

being optimized."


Department heads, Cyagen Biosciences

"Compared with previous electroporator, the

experimental cost is greatly reduced."

Dr. Hu

R&D Director, Genepharma

"Lower cost with stable results."

Some Demo Results

Product Display

Mr. Tan

Associate professor, SINANO of Chinese Academy of Sciences

X-Porator F1 with a maximum single treatment volume of up to 250ml.

293F,TE: 94.2%, V: 92.7%.

CHO-S,TE: 95.0%, V: 98.5%. 

"H1 leads to breakthrough in experiments. The results have been published in the Nano Research this year."

Read more>>

Read more>>

Read more>>